AN EVENT FROM THE FINANCIAL TIMES LTD

Cancer Policy & Economics Conference
Facilitating Access to Therapies in Times of Austerity
ΜΑRCH 8, 2016, DIVANI CARAVEL
08:45-09:15
Registration
09:15-09:30
Welcome remarks
09:30-10:15 Opening Speeches
“The political imperatives to address cancer”
Andreas Xanthos*, Minister of Health
Pascal Apostolides, President of SFEE
10:15-11.30
SESSION 1
THE IMPACT OF CANCER TO PUBLIC HEALTH, ECONOMY AND SOCIETY
Chair: Mary Geitona, Associate Professor at University of Peloponnese, Dept. of Economics
Kyriakos Souliotis*, Assistant Professor of Health Policy at the Faculty of Social Sciences,
University of Peloponnese
Dr Mauro Laudicella*,Senior Lecturer in Health Economics, HSR and Management division at
City University and Honorary Research Fellow, Imperial College Business School & Centre for
Health Policy
Paris Kosmidis, Medical Oncologist at Hygeia Hospital. Past ESMO President
Ioannis-Isidoros Varthalitis*, Medical Oncologist-Infectiologist, General Hospital of Chania,
President of EOPE
Konstantinos Syrigos, M.D., Ph.D. Professor of Medicine & Medical Oncology,
Head of 3rd Department of Medicine, Sotiria General Hospital, Athens School of Medicine,
National & Kapodistrian University, Vis. Professor of Thoracic Oncology, Yale School of
Medicine, USA
Q&A
11:30-12:00
Coffee Break
12:00 – 12:15 Research Presentation
Thanos Kosmidis, Co-founder Care-Across
12:15 – 13:45
SESSION 2
NOVEL APPROACHES TO THE TREATMENT OF CANCER
Chair: Maria Gazouli, Biologist, Assistant Professor of Molecular Biology, Department of Basic
Medical Science Laboratory of Biology, School of Medicine, University of Athens, Greece/
Member, European Technology Platform on Nanomedicine (ETPN)
Othon Iliopoulos, MD, PhD, Associate Professor of Medicine, Harvard Medical School,
Attending Oncologist, Massachusetts General Hospital
George N. Pavlakis, M.D., Ph.D., Head of Human Retrovirus Section, Center for Cancer
Research, National Cancer Institute
Κonstantinos N. Demetzos, Pharmacy Nano-Technology Professor, Greek Pharmaceutical
Society (EFE) President, EUFEPS Executive Committee Member.
Zenia C. Saridaki-Zora, Pathologist-Oncologist, Principal Investigator, Department of Oncology
“Asclepius”, Member of the Greek, European and American Society of Oncology-Pathology
Zoe Grammatoglou, KEFI President
Q&A
13:45 – 14:45 Lunch Break
14:45 – 15:05
Best Practice Presentation: Τhe first “Winners of Cancer” clinic in Greece (NI.KA),
in collaboration with “ΚΥΤΤΑΡΟ” association.
15:05 – 15:45
ACCESS TO CANCER RELATED SERVICES
George Pissakas*, Vice President, Hellenic Society for Radiation Oncology, CoordinatorDirector, Radiation Oncology Department, “Alexandra" Hospital
Dr. Athanassios Dimopoulos*, Department Director- Radiation Oncology, Metropolitan
Hospital
Haralambos Kalofonos*, Professor of Oncology, Medical School, Univ. of Patras
15:45 – 17:15
INNOVATION: VANGUARD IN THE BATTLE AGAINST CANCER
Introductory Speech
Professor David Thurston*, Professor of Drug Discovery, King’s College, London
Roundtable Discussion: Battle against cancer: What’s new on pharma industry
Magda Hatzikou*, Senior Health Economics Manager at Novartis Hellas
Zafeiris Giannopoulos*, Business Unit Head Oncology, MSD Greece
Xenia Caporis*, External Affairs Director, Roche Hellas
Konstantinos Papakostakis*, Brand Manager Oncology, AstraZeneca Hellas
Zefi Kolatakou*, Commercial Strategy Manager Oncology at Pfizer Hellas
George Kalomoiris*, BU Head Oncology, Takeda Hellas
Q&A
17:15 – 17:17.30
Concluding Speech
Elias Mosialos*, Professor of Health Policy, Department of Social Policy, LSE